<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ASeries_A</id>
	<title>Definition:Series A - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ASeries_A"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Series_A&amp;action=history"/>
	<updated>2026-05-02T20:15:06Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Series_A&amp;diff=17034&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Series_A&amp;diff=17034&amp;oldid=prev"/>
		<updated>2026-03-15T10:01:39Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🚀 &amp;#039;&amp;#039;&amp;#039;Series A&amp;#039;&amp;#039;&amp;#039; denotes the first major round of institutional [[Definition:Venture capital (VC) | venture capital]] financing that an [[Definition:Insurtech | insurtech]] startup or insurance-focused technology company raises after its initial [[Definition:Seed funding | seed stage]]. In the insurance sector, a Series A typically signals that the company has moved beyond proof of concept — it has a working product, early traction with [[Definition:Insurance carrier | carriers]], [[Definition:Broker | brokers]], or policyholders, and a credible path to scaling within the highly regulated insurance ecosystem. The round involves issuing Series A [[Definition:Preferred stock | preferred shares]] at a negotiated [[Definition:Valuation | valuation]], making it a [[Definition:Priced round | priced round]] that formally establishes the company&amp;#039;s worth.&lt;br /&gt;
&lt;br /&gt;
📋 Structurally, a Series A for an insurance-sector company tends to range from several million to tens of millions of dollars, though the amount varies considerably by geography and business model. A [[Definition:Managing general agent (MGA) | digital MGA]] writing its own [[Definition:Gross written premium (GWP) | gross written premium]] may need more capital than a pure software-as-a-service vendor selling [[Definition:Policy administration system (PAS) | policy administration systems]], because the MGA must fund regulatory capital, build [[Definition:Reinsurance | reinsurance]] relationships, and absorb early [[Definition:Loss ratio (L/R) | loss ratio]] volatility. Lead investors in insurtech Series A rounds frequently include specialist venture funds with deep insurance expertise, as well as [[Definition:Corporate venture capital (CVC) | corporate venture capital]] arms of major insurers and reinsurers — entities like MS&amp;amp;AD Ventures, [[Definition:Munich Re | Munich Re]] Ventures, or [[Definition:Aviva | Aviva]] Ventures — who can offer distribution partnerships alongside capital. The term sheet will typically grant investors a [[Definition:Board of directors | board seat]], [[Definition:Liquidation preference | liquidation preferences]], [[Definition:Anti-dilution provision | anti-dilution rights]], and veto authority over major corporate decisions.&lt;br /&gt;
&lt;br /&gt;
🔑 Reaching a Series A is widely regarded as one of the most difficult transitions in the insurtech lifecycle, and for good reason. The insurance industry&amp;#039;s long sales cycles, complex regulatory requirements, and entrenched incumbent relationships mean that many startups struggle to demonstrate the customer adoption and revenue momentum that institutional investors require. Companies that do close a Series A gain not only the capital to hire, expand product lines, and pursue licensing in new jurisdictions, but also the credibility boost that comes with a recognized investor&amp;#039;s endorsement — a factor that matters enormously when an [[Definition:Underwriter | underwriter]] or [[Definition:Chief information officer (CIO) | CIO]] at a major carrier is deciding whether to trust a young firm with sensitive data or [[Definition:Delegated underwriting authority (DUA) | delegated authority]]. The round effectively marks the company&amp;#039;s transition from an experiment to an enterprise that the insurance market takes seriously.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Series A funding]]&lt;br /&gt;
* [[Definition:Seed funding]]&lt;br /&gt;
* [[Definition:Venture capital (VC)]]&lt;br /&gt;
* [[Definition:Priced round]]&lt;br /&gt;
* [[Definition:Insurtech]]&lt;br /&gt;
* [[Definition:Corporate venture capital (CVC)]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>